Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.55 |
| ▸ | DUT | P33316 | 2/20 | 0.48 |
| ▸ | TK2 | O00142 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TK1 | P04183 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26176904 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL26176883 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL26176911 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL26176881 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL24207815 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL24207971 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL4454711 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL2821674 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL3485522 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A | |
| SCHEMBL26176900 | 1.00 | KIF11 (0.55) | KIF11DUTTK2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2023-09-21 | — | — | US | disclosed |
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2023-09-21 | — | — | US | disclosed |
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2023-09-21 | — | — | US | disclosed |
| EP-4182296-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | Sanofi Pasteur (FR) | 2023-05-24 | — | — | EP | disclosed |
| WO-2022013439-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | SANOFI PASTEUR (FR) | 2022-01-20 | — | — | WO | disclosed |
| US-10241234-B2 | Silicone hydrogel soft contact lens having wettable surface | HOYA CORPORATION (JP) | 2019-03-26 | — | — | US | disclosed |
| US-9529119-B2 | Method for fabricating silicone-containing copolymer molded article having hydrophilic surface and silicone-hydrogel contact lens having hydrophilic surface | HOYA CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9529119-B2 | Method for fabricating silicone-containing copolymer molded article having hydrophilic surface and silicone-hydrogel contact lens having hydrophilic surface | HOYA CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20160282516-A1 | METHOD FOR FABRICATING SILICONE-CONTAINING COPOLYMER MOLDED ARTICLE HAVING HYDROPHILIC SURFACE AND SILICONE-HYDROGEL CONTACT LENS HAVING HYDROPHILIC SURFACE | HOYA CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160282516-A1 | METHOD FOR FABRICATING SILICONE-CONTAINING COPOLYMER MOLDED ARTICLE HAVING HYDROPHILIC SURFACE AND SILICONE-HYDROGEL CONTACT LENS HAVING HYDROPHILIC SURFACE | HOYA CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| WO-2012122144-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | WU NIAN (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | BIOZONE PHARMACEUTICALS, INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | BIOZONE PHARMACEUTICALS, INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-20110040113-A1 | Pure PEG-lipid conjugates | WU NIAN | 2011-02-17 | — | — | US | disclosed |
| US-20110040113-A1 | Pure PEG-lipid conjugates | WU NIAN | 2011-02-17 | — | — | US | disclosed |
| US-7655768-B2 | Galactose derivative, drug carrier and medicinal composition | NIPPON SHINYAKU CO., LTD. (JP) | 2010-02-02 | — | — | US | disclosed |
| US-20070244058-A1 | Galactose Derivative, Drug Carrier and Medicinal Composition | NIPPON SHINYAKU CO., LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
| EP-1783137-A1 | GALACTOSE DERIVATIVE, DRUG CARRIER AND MEDICINAL COMPOSITION | Nippon Shinyaku Co., Ltd. (JP) | 2007-05-09 | — | — | EP | disclosed |
| EP-0540612-A1 | HETEROBIFUNCTIONAL REAGENTS AND CONJUGATES WITH OXAALKYLENE UNITS FOR AMPHIPHILIC BRIDGE STRUCTURES | Pharmacia AB (SE) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992001474-A1 | HETEROBIFUNCTIONAL REAGENTS AND CONJUGATES WITH OXAALKYLENE UNITS FOR AMPHIPHILIC BRIDGE STRUCTURES | KABI PHARMACIA AB (SE) | 1992-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293447-A1 | CLEAVABLE LIPIDIC COMPOUNDS, COMPOSITIONS CONTAINING THEREOF, AND USES THEREOF | MTTP, CETP, LNPEP | KIF11 2133/4885DUT 669/4885TK2 2315/4885 |
| US-20120232169-A1 | HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES | LIPA, CETP, DGAT2 | KIF11 417/4885DUT 422/4885TK2 1335/4885 |
| US-20110040113-A1 | Pure PEG-lipid conjugates | DGAT2, MGLL, DGAT1 | KIF11 675/4885DUT 763/4885TK2 2220/4885 |
| US-20070244058-A1 | Galactose Derivative, Drug Carrier and Medicinal Composition | GALK1, GALE, UGGT1 | KIF11 3644/4885DUT 138/4885TK2 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.